MOLECULAR TECHNOLOGIES III

CRB 834

Course Description

Covers topics and concepts in the drug discovery process, with emphasis on laboratory assays and methods used in primary, secondary, and in vitro ADMETox (Absorption, Distribution, Metabolism, Excretion, Toxicity) drug screening. In addition, students build communication and critical thinking skills while working on team projects and analyzing scientific results.

Prerequisties

Declared in the Biotechnology graduate program

Satisfies

This course does not satisfy any prerequisites.

Credits

Offered

Fall

Grade Point Average

3.94

-0.6% from Historical

Completion Rate

100%

No change from Historical

A Rate

88.46%

-5.14% from Historical

Class Size

13.49% from Historical

2025 Fall Grade Distribution

Instructors (2025 Fall)

Sorted by ratings from Rate My Professors

NATALIE BETZ

[email protected]

Rating

Similar Courses

MOLECULAR TECHNOLOGIES I

CRB 803

An intensive workshop that will teach biotechniques, biotechnology product development, and biotechnology applications interfaced with analytical, communication and teaching skills. Simulates the corporate and academic biotechnology setting.

MOLECULAR TECHNOLOGIES III: ASSAY DEVELOPMENT

BIOMDSCI 823

Evaluate laboratory assays and methods used in primary, secondary, and in vitro ADMETox (Absorption, Distribution, Metabolism, Excretion, Toxicity) drug screening. Build scientific communication and critical thinking skills while working on team projects and analyzing scientific results.

MOLECULAR TECHNOLOGIES II

CRB 824

EARLY DRUG DISCOVERY

BIOMDSCI 820

Examine the early drug discovery process, including target identification and validation, generation of diverse chemical libraries, assay development and high throughput screening, lead optimization by compound profiling, and drug targeting and delivery.

EARLY DRUG DISCOVERY

CRB 830

Provides an overview of the early drug discovery process, including target identification and validation, generation of diverse chemical libraries, assay development and high throughput screening, lead optimization by compound profiling, and drug targeting and delivery.